Heart Failure, diabetes patients benefit from metformin
A recent study involving older U.S. adults hospitalized for heart failure (HF) with comorbid diabetes found metformin initiation to be independently associated with substantial improvements in 12-month clinical outcomes. This was driven by findings among patients with an ejection fraction (EF) >40%. Conversely, regardless of EF, sulfonylurea initiation was related to excess risk of death and HF hospitalization.
According to the study, starting metformin treatment in patients with type 2 diabetes shortly after they were hospitalized for heart failure was linked with a reduced rate of repeat hospitalization for heart failure (HHF) during the subsequent year when their left ventricular ejection fraction (LVEF) was greater than 40%.
For more information check out the link below:
Metformin improves outcomes in patients with HF and diabetes, finds Study
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.